André-Michel Ballester served as the CEO of LivaNova PLC from 2015 until 2016. He has a solid educational background with a Master of Science in Chemical Engineering and an MBA from distinguished institutions in France. Before joining LivaNova, he gained...
André-Michel Ballester served as the CEO of LivaNova PLC from 2015 until 2016. He has a solid educational background with a Master of Science in Chemical Engineering and an MBA from distinguished institutions in France. Before joining LivaNova, he gained experience at Sorin, Edwards Lifesciences, and Baxter, indicating a strong track record in the medical technology sector. He resigned from LivaNova at the end of 2016 but left a notable impact. His annual compensation reflects his leadership role, reaching up to $700,000 in 2015, primarily through salary and performance bonuses. After resigning, he entered a consulting agreement with LivaNova where he provided transitional support and was involved in litigation as needed. Interestingly, he had around 80,959 shares in the company at the time of his departure, which indicates a personal investment in the company's future. His broad experience in medical technology and management provides depth to his role as a leader.